Trials / Conditions / Transcatheter Aortic Valve Replacement (TAVR)

Transcatheter Aortic Valve Replacement (TAVR)

14 registered clinical trials studyying Transcatheter Aortic Valve Replacement (TAVR) — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	TAVR for Aortic Regurgitation Under TTE Guidance NCT07458672	Chinese Academy of Medical Sciences, Fuwai Hospital	N/A
Not Yet Recruiting	Prospective, Long-term Evaluation of the SAPIEN 3 Ultra RESILIA Valve NCT06953206	Institut für Pharmakologie und Präventive Medizin	—
Recruiting	Frequency of Electrical Acupoint Stimulation on Hypotension in TAVR Patients NCT07365345	Air Force Military Medical University, China	N/A
Not Yet Recruiting	CardioLogical Interventions and Acute strOke Treatment sTudy NCT07314476	University of L'Aquila	—
Recruiting	Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging NCT07455292	IRCCS Policlinico S. Donato	N/A
Recruiting	Assessment of Coronary Artery Disease Before Transcatheter Aortic Valve Replacement: A Randomized, Multicenter NCT07107568	Medical University Innsbruck	N/A
Recruiting	Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease NCT07267117	Second Affiliated Hospital, School of Medicine, Zhejiang University	—
Enrolling By Invitation	A Clinical Study on the Use of the Sentinel Cerebral Protection Device During TAVR for the Prevention of Proce NCT07045233	China National Center for Cardiovascular Diseases	—
Recruiting	TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System NCT06818084	Ruijin Hospital	Phase 4
Not Yet Recruiting	RAFT-TAVR PACE: LBBAP Vs. RVP Post-TAVR in Patients Requiring PPI NCT06857201	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	N/A
Completed	EasyCrossTM Device-Self-centering Catheter NCT06412354	Vivheart s.r.l.	N/A
Unknown	Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation NCT05283356	Fundacin Biomedica Galicia Sur	Phase 4
Completed	Outcomes for Patients With Ascending Aortic Dilation Who Underwent TAVR NCT07148973	zjq	—
Withdrawn	Transcatheter Aortic Valve Replacement (TAVR)-Pilot Trial NCT02723422	NYU Langone Health	N/A